Le Lézard
Classified in: Health, Business
Subjects: EARNINGS, Conference Calls/ Webcasts

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update


VANCOUVER, British Columbia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it will report its fourth quarter and full year 2023 financial and operating results after the close of U.S. financial markets on Thursday, February 29, 2024.

Conference Call/Webcast Information:

Date:  Thursday, February 29, 2024
Time: 4:30 pm Eastern Time (1:30 pm Pacific Time)
Dial-In: (800) 715-9871 or (646) 307-1963 for international callers
Conference ID: 9376408

A live audio webcast will be available on the "Investors" section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need. For more information, please visit www.xenon-pharma.com.

"Xenon" and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: [email protected] 



These press releases may also interest you

at 16:01
Sola Salon Studios Coming to Medford, Oregon in May 2024
Sola Salons, the world's largest studio suites franchise for more than 20,000 independent beauty professionals, proudly announces the opening of its Southern Oregon location in Medford, Oregon. In 2004, Sola Salons was the first in the industry to...

at 13:45
BLUE INVESTOR NEWS: TOP RANKED ROSEN LAW FIRM Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio, Inc. between April 24, 2023 and December 8, 2023, both dates inclusive (the "Class Period"), of the important May 28, 2024 lead plaintiff...

at 11:25
Prospera Energy Inc. Debt Settlement
Prospera Energy Inc. ("Prospera" or the "Corporation") (PEI: TSX-V; OF6A:FRA) announced that it has agreed to settle claims from a former executive by the payment of $120,000 over a period of 6 months, and by the issuance of 2,181,818 common shares...

at 10:30
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Plug Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PLUG
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Plug Power Inc. between May 9, 2023 and January 16, 2024, both dates inclusive (the "Class Period"), of the important May 21, 2024 lead plaintiff deadline....

at 10:30
Flourishing Foundations Recovery Opens New Outpatient Drug and Alcohol Detox Facility in San Antonio, TX
Flourishing Foundations Recovery has launched a new outpatient detox center in San Antonio, TX, aiming to help individuals tackle drug and alcohol addiction without pausing their daily lives. The new substance abuse treatment center ensures easy...

at 10:00
Inspry Sharpens Focus on WordPress and WooCommerce Development Services
Having led over a decade of successful WordPress projects, Inspry has proven itself as a reliable technical...

More news about Business...


News published on and distributed by: